Outlook Therapeutics Inc Stock Market Value
| OTLK Stock | USD 1.70 3.19 65.24% |
| Symbol | OUTLOOK |
OUTLOOK THERAPEUTICS INC Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.89) | Revenue Per Share 0.119 | Quarterly Revenue Growth 6.583 | Return On Assets (0.84) | Return On Equity (0.04) |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
OUTLOOK THERAPEUTICS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OUTLOOK THERAPEUTICS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OUTLOOK THERAPEUTICS.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in OUTLOOK THERAPEUTICS on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding OUTLOOK THERAPEUTICS INC or generate 0.0% return on investment in OUTLOOK THERAPEUTICS over 30 days. OUTLOOK THERAPEUTICS is related to or competes with Checkpoint Therapeutics, Mustang Bio, Reviva Pharmaceuticals, Fortress Biotech, Kodiak Sciences, Protalix Biotherapeutics, and Eyepoint Pharmaceuticals. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing m... More
OUTLOOK THERAPEUTICS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OUTLOOK THERAPEUTICS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OUTLOOK THERAPEUTICS INC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 18.95 | |||
| Value At Risk | (8.30) | |||
| Potential Upside | 5.88 |
OUTLOOK THERAPEUTICS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OUTLOOK THERAPEUTICS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OUTLOOK THERAPEUTICS's standard deviation. In reality, there are many statistical measures that can use OUTLOOK THERAPEUTICS historical prices to predict the future OUTLOOK THERAPEUTICS's volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (1.72) | |||
| Total Risk Alpha | (2.89) | |||
| Treynor Ratio | (1.16) |
OUTLOOK THERAPEUTICS INC Backtested Returns
OUTLOOK THERAPEUTICS INC maintains Sharpe Ratio (i.e., Efficiency) of -0.16, which implies the firm had a -0.16% return per unit of standard deviation over the last 3 months. OUTLOOK THERAPEUTICS INC exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OUTLOOK THERAPEUTICS's Market Risk Adjusted Performance of (1.15), coefficient of variation of (565.90), and Risk Adjusted Performance of (0.13) to confirm the risk estimate we provide. The company holds a Beta of 1.35, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, OUTLOOK THERAPEUTICS will likely underperform. At this point, OUTLOOK THERAPEUTICS INC has a negative expected return of -1.47%. Please make sure to check OUTLOOK THERAPEUTICS's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if OUTLOOK THERAPEUTICS INC performance from the past will be repeated at some future point.
Auto-correlation | 0.04 |
Virtually no predictability
OUTLOOK THERAPEUTICS INC has virtually no predictability. Overlapping area represents the amount of predictability between OUTLOOK THERAPEUTICS time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OUTLOOK THERAPEUTICS INC price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current OUTLOOK THERAPEUTICS price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | -0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 1.83 |
OUTLOOK THERAPEUTICS INC lagged returns against current returns
Autocorrelation, which is OUTLOOK THERAPEUTICS stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting OUTLOOK THERAPEUTICS's stock expected returns. We can calculate the autocorrelation of OUTLOOK THERAPEUTICS returns to help us make a trade decision. For example, suppose you find that OUTLOOK THERAPEUTICS has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
OUTLOOK THERAPEUTICS regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If OUTLOOK THERAPEUTICS stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if OUTLOOK THERAPEUTICS stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in OUTLOOK THERAPEUTICS stock over time.
Current vs Lagged Prices |
| Timeline |
OUTLOOK THERAPEUTICS Lagged Returns
When evaluating OUTLOOK THERAPEUTICS's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of OUTLOOK THERAPEUTICS stock have on its future price. OUTLOOK THERAPEUTICS autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, OUTLOOK THERAPEUTICS autocorrelation shows the relationship between OUTLOOK THERAPEUTICS stock current value and its past values and can show if there is a momentum factor associated with investing in OUTLOOK THERAPEUTICS INC.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out OUTLOOK THERAPEUTICS Correlation, OUTLOOK THERAPEUTICS Volatility and OUTLOOK THERAPEUTICS Alpha and Beta module to complement your research on OUTLOOK THERAPEUTICS. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
OUTLOOK THERAPEUTICS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.